Pratheeshkumar Poyil

Dr. Pratheeshkumar Poyil

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
ABAmit Budhraja
Amit Budhraja
Youngok SonYoungok Son
Youngok Son
XWXin Wang
Xin Wang
ZZZhuo Zhang
Zhuo Zhang
XSXianglin Shi
Xianglin Shi
Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.

1 August 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JLJeong-Chae Lee
Jeong-Chae Lee
Youngok SonYoungok Son
Youngok Son
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
XSXianglin Shi
Xianglin Shi

1 August 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YWYuting Wang
Yuting Wang
AMArdhendu Kumar Mandal
Ardhendu Kumar Mandal
YSYoung-Ok Son
Young-Ok Son
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
JWJames TF Wise
James TF Wise
ZCZhimin Chen
Zhimin Chen

1 June 2013 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YYYuanqin Yin
Yuanqin Yin
WLWenqi Li
Wenqi Li
Youngok SonYoungok Son
Youngok Son
LSLijuan Sun
Lijuan Sun
JLJian Lu
Jian Lu
ZZZhuo Zhang
Zhuo Zhang

1 November 2012 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
CSChakkenchath Sreekala
Chakkenchath Sreekala
ZZZhuo Zhang
Zhuo Zhang
ABAmit Budhraja
Amit Budhraja
SDSongze Ding
Songze Ding
XSXianglin Shi
Xianglin Shi
Cancer is the second leading cause of death worldwide. There is greater need for more effective and less toxic therapeutic and preventive strategies. Natural products are becoming an important research area for novel and bioactive molecules for drug discovery. Phytochemicals and dietary compounds have been used for the treatment of cancer throughout history due to their safety, low toxicity, and general availability. Many active phytochemicals are in human clinical trials. Studies have indicated that daily consumption of dietary phytochemicals have cancer protective effects against carcinogens. They can inhibit, delay, or reverse carcinogenesis by inducing detoxifying and antioxidant enzymes systems, regulating inflammatory and proliferative signaling pathways, and inducing cell cycle arrest and apoptosis. Epidemiological studies have also revealed that high dietary intakes of fruits and vegetables reduce the risk of cancer. This review discusses potential natural cancer preventive compounds, their molecular targets, and their mechanisms of actions.

21 September 2011 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
GKGirija Kuttan
Girija Kuttan
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
KMKanjoormana Aryan Manu
Kanjoormana Aryan Manu
RKRamadasan Kuttan
Ramadasan Kuttan
Context: Cancer is a major public health problem in India and many other parts of the world. Its two main characteristics are uncontrolled cell growth and metastasis. Natural products represent a rich source of compounds that have found many applications in various fields of medicines and therapy including cancer therapy. Effective ingredients in several plant-derived medicinal extracts are terpenoid compounds and many terpenes have biological activities and are used for the treatment of human diseases. Objectives: This review attempted to collect all available published scientific literature of eight naturally occurring terpenoids and their effect on inhibition of tumor progression. Methods: The present review is about eight potent naturally occurring terpenoids that have been studied for their pharmacological properties in our lab and this review includes 130 references compiled from all major databases. Results: Literature survey revealed that triterpenoids, such as glycyrrhizic acid, ursolic acid, oleanolic acid, and nomilin, the diterpene andrographolide, and the monoterpenoids like limonene and perillic acid had shown immunomodulatory and antitumor activities. All of them could induce apoptosis in various cancer cells by activating various proapoptotic signaling cascades. Many of these terpenoids found to inhibit metastatic progression and tumor-induced angiogenesis. The molecular mechanisms that involved in these activities include inhibition of various oncogenic and anti-apoptotic signaling pathways and suppression or nuclear translocation of various transcription factors including nuclear factor kappa B (NF-κB). Conclusion: The chemopreventive and chemoprotective effects of these compounds point toward their possible role in modern anticancer therapies.